Published in Cancer on January 17, 2012
Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using (18)F-FDG PET/CT. Nucl Med Mol Imaging (2016) 1.06
Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol (2013) 0.87
Fine-needle aspirates CYFRA 21-1 is a useful tumor marker for detecting axillary lymph node metastasis in breast cancer patients. PLoS One (2013) 0.80
Distant recurrence risk following early ipsilateral breast tumor recurrence. Oncol Lett (2017) 0.75
Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up. Clinics (Sao Paulo) (2017) 0.75
Local Recurrence after Breast-Conserving Surgery and Mastectomy Following Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer - a Meta-Analysis. Breast Care (Basel) (2016) 0.75
Oncological safety of breast-conserving surgery after primary systemic chemotherapy in cT3-4 breast cancer patients. Surg Today (2014) 0.75
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients. J Clin Oncol (2010) 3.21
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol (2008) 2.90
One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res (2007) 2.36
Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol (2006) 2.04
Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer. World J Surg (2009) 2.02
Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes. Eur J Cancer (2012) 2.01
Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation. J Biol Chem (2006) 1.99
Long-term course of Dravet syndrome: a study from an epilepsy center in Japan. Epilepsia (2014) 1.99
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese. Hum Mol Genet (2011) 1.91
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat (2002) 1.69
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast (2007) 1.64
Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity (2004) 1.63
Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol (2008) 1.62
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer (2006) 1.57
Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg (2006) 1.53
Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res (2009) 1.52
Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol (2006) 1.51
Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations. J Thorac Cardiovasc Surg (2005) 1.45
Pathophysiology of seroma in breast cancer. Breast Cancer (2005) 1.43
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. Int J Clin Oncol (2005) 1.42
Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer. J Thorac Oncol (2011) 1.41
Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg (2006) 1.41
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39
Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer (2008) 1.37
Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med (2008) 1.36
Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer (2009) 1.30
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer (2006) 1.28
Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. Jpn J Clin Oncol (2007) 1.28
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer (2005) 1.27
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer (2013) 1.26
Flare-up of dermatomyositis along with recurrence of breast cancer. Breast J (2007) 1.25
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival. Breast Cancer Res Treat (2007) 1.25
Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer (2010) 1.23
Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res (2002) 1.20
A case of carcinosarcoma of the breast. Breast Cancer (2005) 1.18
Effect of mechanical closure of dead space on seroma formation after breast surgery. Breast Cancer (2006) 1.18
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol (2010) 1.18
Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer (2002) 1.18
Epidermal inclusion cyst of the breast. Breast Cancer (2007) 1.17
Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol (2002) 1.17
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur J Cancer (2006) 1.16
Clinical and pathological features of intracystic papillary carcinoma of the breast. Surg Today (2009) 1.16
Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol (2004) 1.15
The 3' enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells. Immunity (2012) 1.14
Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood (2010) 1.13
The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold. Bioorg Med Chem Lett (2005) 1.12
Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers. Int J Cancer (2002) 1.11
Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res (2005) 1.10
Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer. Int J Clin Oncol (2008) 1.10
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer (2005) 1.10
Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology (2006) 1.08
General rules for clinical and pathological recording of breast cancer 2005. Breast Cancer (2005) 1.08
p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology (2003) 1.08
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer. Jpn J Clin Oncol (2011) 1.07
Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. Hum Pathol (2010) 1.06
Metastatic breast carcinoma of the abdominal wall muscle: a case report. Breast Cancer (2012) 1.06
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. Breast Cancer (2006) 1.05
Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg (2003) 1.04
Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer (2011) 1.03
A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res (2012) 1.02
Intracystic papillary carcinoma of the breast in a male patient diagnosed by core needle biopsy: a case report. Breast (2005) 1.02
Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer. Surgery (2003) 1.02
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer (2009) 1.02
Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. J Immunol (2005) 1.01
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial. Support Care Cancer (2012) 1.00
Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer (2003) 1.00
Sentinel node biopsy for breast cancer: technical aspects and controversies. Breast Cancer (2007) 1.00
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer. Breast Cancer (2006) 0.99
Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer (2006) 0.99
Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol (2009) 0.99
Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer (2009) 0.99